Low Transmissibility of Mycobacterium tuberculosis Based

LowTransmissibilityofMycobacteriumtuberculosisBasedonTimetoDetec6onfromPa6entswithanIni6alSputumPosi6vebyLiquidCulturebutNega6vebyNucleicAcidAmplifica6onTes6ngandAcid-FastBacilliStainSaahirKhan1,AudreyNakasone2,MinooGhajar3,MariamZhowandai3,SunitaPrabhu3,RickAlexander3,JulieLow4,EllenaPeterson2,andLauriThrupp1,2,5

1DivisionofInfec6ousDiseases,2ClinicalMicrobiologyLaboratory,5EpidemiologyandInfec6onPreven6on,UniversityofCaliforniaIrvineHealth,Orange,California3PublicHealthLaboratory,4TuberculosisControlDivision,OrangeCountyHealthcareAgency,SantaAna,California

Background

Tradi6onalguidelinesforde-isola6onofsuspectedpulmonaryTBcasesrequirethreerespiratoryspecimenscollectedandtestednega6vebyacid-fastbacilli(AFB)staining1,2(basedonstudiesshowingnega6veAFBindicateslowerorganismburdenandtransmissionrisk5,9)butrequirepa6entstospendtwoormoredaysincostlyairborneisola6onrooms3.

Ofconcernwiththisapproach,30-50%ofspecimensfromcultureposi6vepulmonaryTBcaseshavenega6veAFBstain4,and17%ofnewcasetransmissionsareacquiredfromAFB-nega6vecases5.

Recently,useofnucleicacidamplifica6ontests(NAAT)hasincreasedsensi6vityforTBdiagnosis6,promp6ngstudiessugges6ngde-isola6onaaeronespecimenwithnega6veAFBstainandnega6veNAAT5,6,11.

However,thisstrategymays6llmiss10-20%ofculture-posi6veAFBnega6vespecimens,promp6ngrecentguidelinessugges6ngtwospecimenswithnega6veNAATberequiredforde-isola6on7,8.

O’sheaetal.foundthat6metodetec6on(TTD)inliquidcultureof9ormoredaysindicatedlowertransmissionriskbederthanAFBstain10.

Figure1.Transmissionratesandpropor6onofsecondarycasesofac6vediseaseandlatentinfec6on(LTBI)stra6fiedby6me-to-detec6on.ReprintedfromO'Sheaetal.,ClinInfectDis,2014.

TTDhasnotyetbeenexaminedalongwithAFBstainandNAATtodetermineifTTDaddssubstan=vesupporttotheconceptofde-isola=onaAeronespecimennega=vebyAFBandNAAT.

PrincipalAim

ToevaluatewhetherpredictedTTD,incombina=onwithAFBandNAATtoiden=fylowriskcasesofsuspectedpulmonaryTB,supportsthegoalofde-isola=onaAeronespecimennega=veforAFBandNAAT

Methodology

Retrospec6veanalysisofacohortofall117pa6entstestedatU.C.IrvineHealth(UCI)from2013to2014and670pa6entstestedatOrangeCountyHealthCareAgency(OCHCA)in2014iden6fiedatotalof94Mtbculture-posi6vefirstrespiratoryspecimens(34atUCI,60atOCHCA).

EachspecimenwasassessedbyAFBgradewithKinyounstain,TTDinMGITculture,andNAATresultbyCepheidXpertonfresh(OCHCA)orstoredfrozen(UCI)rou6neconcentrates.

Figure2.KinyounstainforAFB(lea),MGITforliquidculture(middle),andCepheidXpertforNAAT(right).

Weanalyzedcorrela6onbetweenAFBgradeandTTDusingPearsoncorrela6oncoefficientwithStudent’st-testforgroupcomparisons.

Results

TimetoDetec=on,AFBGrade,andNAATResultfor94MtbCulture-Posi=veFirst-RespiratorySpecimens

Figure3.Timetodetec6onincultureversusAFBgradeandNAATresultfor94specimensanalyzed,stra6fiedintolowriskoftransmissionwithTTD>9daysandhighriskoftransmissionwithTTD<9days.

Among94totalspecimens,61specimens(65%)wereposi6vebyAFBstainandNAAT,andanaddi6onal21(22%)wereposi6vebyNAATalone,leaving12specimensofinterest(13%)thatwereposi6vebyMtbsolidculturebutnega6vebybothAFBstainandNAAT.

Figure4.94specimensanalyzedbyAFBgrade,NAATresult,andTTDwerestra6fiedintoahightransmissionriskgroup(pink)withposi6veAFBstainorposi6veNAATorTTDlessthan9daysandalowtransmissionrisk

group(blue)withnega6veAFBstain,nega6veNAAD,andTTDgreaterthanorequalto9days.

All12specimenswithnega6veAFBstainandNAAThadTTDof9daysorgreaterindica6nglowerriskofMtbtransmission(seeFigure3onlea).

TTDhasstronginverselinearcorrela6onwithAFBgrade(ρ=0.62).

Figure5.Mean6metodetec6onwithcorrela6ontosputumAFBgrade(errorbarsrepresentSEM)

Discussion/Conclusion

Nega6veAFBstainandNAATpredictTTDof9daysorgreater,allofwhichindicateloworganismburdenpredic6nglowtransmissionrisk.

Thesefindingssupportearlyde-isola6onaaeronespecimenwithnega6veAFBstainandNAATsincetheculture-posi6vesubsetofthesepa6entsallhadTTDof9daysorgreaterindica6nglowtransmissionrisk.

Addi6onally,inves6ga6onsofcontactswithprolongedexposureslikelyoveres6matetransmissionriskinhospitalseongswithbriefexposures.

UCInowallowsremovalofairborneisola6onforsuspectedpulmonaryTBcases(withoutcavi6es,miliarypadern,orimmunosuppression)aaeronespecimennega6vebybothAFBstainandNAAT.

***

1.  Taylor,Z.,etal.,ControllingtuberculosisintheUnitedStates.Recommenda9onsfromtheAmericanThoracicSociety,CDC,andtheInfec9ousDiseasesSocietyof

America.MMWRRecommRep,2005.54(RR-12):p.1-81.2.  Erkens,C.G.,etal.,Tuberculosiscontactinves9ga9oninlowprevalencecountries:aEuropeanconsensus.EurRespirJ,2010.36(4):p.925-49.3.  Kalimuddin,S.,Tan,J.M.M.,Tan,B.H.&Low,J.G.H.Aretrospec9vereviewofater9aryHospital'sisola9onandde-isola9onpolicyforsuspectedpulmonary

tuberculosis.BMCInfect.Dis.,2014.14,547.4.  Dud,A.K.,Stead,W.W.Smear-nega9vepulmonarytuberculosis.SeminRespirInfect,1994.9:113-119.

5.  Behr,M.A.etal.TransmissionofMycobacteriumtuberculosisfrompa9entssmear-nega9veforacid-fastbacilli.Lancet,1999.353:444–449.6.  Chaisson,L.H.etal.ImpactofGeneXpertMTB/RIFAssayonTriageofRespiratoryIsola9onRoomsforInpa9entswithPresumedTuberculosis:AHypothe9cal

Trial.ClinInfectDis,2014.59:1353.7.  Na6onalTuberculosisControllersAssocia6on.ConsensusstatementontheuseofCepheidXpertMTB/RIFassayinmakingdecisionstodiscon9nueairborne

infec9onisola9oninhealthcareseOngs.April,2016.8.  Lipincod,C.K.,etal.XpertMTB/RIFassayshortensairborneisola9onforhospitalizedpa9entswithpresump9vetuberculosisintheUnitedStates.ClinInfectDis,

2014.59:186.

9.  Cruz-Ferro,E.,etal.EpidemiologyoftuberculosisinGalicia,Spain,16yearsaSerthelaunchoftheGaliciantuberculosisprogramme.IntJTubercLungDis,2014.18,134–140.

10.  O'Shea,M.K.,etal.,Time-to-detec9oninculturepredictsriskofMycobacteriumtuberculosistransmission:acohortstudy.ClinInfectDis,2014.59(2):177-185.11.  Campos,M.,etal.Feasibilityofshorteningrespiratoryisola9onwithasinglesputumnucleicacidamplifica9ontest.AmJRespirCritCareMed,2008.178:300.12.  Millman,A.J.,etal.Rapidmoleculartes9ngforTBtoguiderespiratoryisola9onintheU.S.:acost-benefitanalysis.PLoSOne,2013.8:e79669.

MtbCulturePosi6ve94(100%)

AFBStainPosi6ve61(65%)

AFBStainNega6ve33(35%)

MtbNAATPosi6ve21(22%)

MtbNAATNega6ve12(13%)

MtbTTD>9Days12(13%)

MtbTTD<9Days

0

Abstract57911

0

10

20

30

40TimetoDetec=o

n(Days)

AFBGrade:negneg1+2+3+4+TotalNAATResult:negposposposposposN=94

higherrisk

lowerrisk

NAAT TTD Smear Total0 1+ 2+ 3+ 4+

Nega6ve <9days 0 0 0 0 0 0 12≥9days 12 0 0 0 0 12

Posi6ve <9days 1 1 3 8 10 23 82≥9days 20 12 15 11 1 59Total 33 13 18 19 11 94

Rela6veRiskofTransmission:TTD>9days=0.4410

AFBnega6ve=0.19-0.225,9

lowerrisk higherrisk

TTD=-3.5*(AFB)+23DoublingTime=25hours

0

5

10

15

20

25

0 1+ 2+ 3+ 4+MeanTimetoDetec=o

n(Days)

SputumAFBGrade

References